Khyber Medical University, Pakistan.
Ministry of Health Saudi Arabia, General Directorate of Health Affairs, Riyadh Region, Riyadh, Saudi Arabia.
Nicotine Tob Res. 2019 Jan 1;21(1):32-40. doi: 10.1093/ntr/ntx281.
With an annual increase of 16000 new cases each year, oral cancer is the second most common cancer in Pakistan. There is conflicting evidence regarding the carcinogenicity of different forms of smokeless tobacco (SLT) from different countries. This difference in evidence may be attributed to the varied composition of SLT products used around the world, necessitating the establishment of individual risks related to each SLT product.
An electronic search in relevant databases yielded 119 publications, out of which six were included in this review. Effect estimates (odds ratios (ORs)) were abstracted or calculated from the given data. A fixed effects meta-analysis was performed to assess the risk of oral cancer with the use of Naswar. Population attributable fractions (PAF) were also calculated.
The Meta Odds Ratio (mOR) for oral cancer associated with the "ever use" of Naswar compared to "never use" was 11.8 (95% CI = 8.4-16.4), I2 = 67%. The pooled estimate for oral cancer in "Ever-users" of Naswar compared to "Never-users," in the Khyber Pakhtunkhwa province was 18.3 (95% CI = 8.7-38.5), I2 = 0%. The PAF for oral cancer associated with the use of Naswar in Pakistan was 44% (95% CI = 35-53).
This review highlights a strong relationship between oral cancer incidence and the use of Naswar in Pakistan and adds to the evidence base on the carcinogenicity of SLT products in humans. Although the synthesized evidence may not be of a high quality, it represents the "best available evidence" which can be used to inform policy.
The carcinogenicity of Naswar, a form of smokeless tobacco used extensively in Pakistan, Afghanistan, and Central Asia, has yet to be recognized by the International Agency for Research on Cancer (IARC), partly due to the lack of evidence on the association of Naswar use and cancer. Additionally, Naswar is yet un-regulated in Pakistan and evades the tax net, resulting in it being freely available to both adults and children at very cheap prices compared to cigarettes, which has been the main focus of tobacco control in Pakistan. This review provides ample evidence for the IARC to declare Naswar as carcinogenic, as well as the Government of Pakistan to regulate the production and sale of Naswar.
在巴基斯坦,口腔癌每年新增病例达 16000 例,是第二大常见癌症。不同国家的不同形式的无烟烟草(SLT)的致癌性证据相互矛盾。这种证据的差异可能归因于世界各地使用的 SLT 产品的组成不同,因此需要确定与每种 SLT 产品相关的个体风险。
在相关数据库中进行电子检索,共获得 119 篇文献,其中 6 篇纳入本综述。从提供的数据中提取或计算效应估计值(比值比(ORs))。采用固定效应荟萃分析评估使用鼻烟的口腔癌风险。还计算了人群归因分数(PAF)。
与从不使用鼻烟相比,使用鼻烟的口腔癌的Meta 比值比(mOR)为 11.8(95%置信区间为 8.4-16.4),I2=67%。在开伯尔-普赫图赫瓦省,与从不使用鼻烟相比,鼻烟“使用者”中口腔癌的合并估计值为 18.3(95%置信区间为 8.7-38.5),I2=0%。与巴基斯坦使用鼻烟相关的口腔癌的 PAF 为 44%(95%置信区间为 35-53)。
本综述强调了在巴基斯坦,口腔癌发病率与鼻烟使用之间存在很强的关系,并为 SLT 产品在人类中的致癌性提供了更多证据。尽管综合证据的质量可能不高,但它代表了可以用于为政策提供信息的“最佳现有证据”。
鼻烟是一种在巴基斯坦、阿富汗和中亚广泛使用的无烟烟草形式,其致癌性尚未得到国际癌症研究机构(IARC)的认可,部分原因是缺乏鼻烟使用与癌症之间关联的证据。此外,鼻烟在巴基斯坦尚未受到监管,且逃税,与香烟相比,它的价格非常便宜,因此对儿童和成人都有很大的吸引力,而香烟一直是巴基斯坦烟草控制的主要重点。本综述为 IARC 将鼻烟宣布为致癌物质以及巴基斯坦政府监管鼻烟的生产和销售提供了充分的证据。